Disperazol Pharma, a leading biotechnology firm that develops compounds that dismantle biofilms of critical Gram—negative pathogens, today announced that it has joined the AMR Industry Alliance.
Innate Pharma (IPHA) announced the first patient was dosed in its Phase 1 study, investigating the safety and tolerability of IPH4502, an Antibody-Drug Conjugate, in patients with advanced solid ...
News Medical on MSN2d
Bruker launches infrared imaging microscope for pharma and life science researchBruker Corporation announced the launch of the LUMOS™ II ILIM , a quantum cascade laser (QCL) based infrared imaging ...
OS Therapies (OSTX) announced it has entered into an asset purchase agreement to acquire the listeria monocytogenes-based immuno-oncology ...
HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a ...
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...
NORTHFIELD, Minn., Jan. 28, 2025 /PRNewswire/ -- Aurora Pharmaceutical, a leading manufacturer of animal health products, is excited to announce the appointment of Stephanie Hastings as its new ...
Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...
Could the drug ads that flash across your television screen offering better health soon be coming to an end? President Donald Trump’s nominee for health and human services secretary, Robert F.
NORTHFIELD, Minn., Jan. 28, 2025 /PRNewswire/ -- Aurora Pharmaceutical, a leading manufacturer of animal health products, is excited to announce the appointment of Stephanie Hastings as its new ...
1 Day VRTX -0.71% DJIA 0.38% S&P 500 0.53% Health Care/Life Sciences 0.19% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback